Magna Terra Reports Gold Assays and Greatly Expands Footprint of the Fournier Lake Gold Property on Its Rocky Brook Project

Toronto, Ontario–(Newsfile Corp. – December 1, 2025) – Magna Terra Minerals Inc. (TSXV: MTT) (the “Company” or “Magna Terra“) is pleased to announce results from its initial exploration work program on the Fournier Lake Gold Property, Rocky Brook Project (“Rocky Brook” or the “Project”), located in the prolific Bathurst Mining Camp (“BMC”) of northern New Brunswick (Figure […]

Zodiac Gold Announces Initial Trenching Results at the Ben Ben Target, including 30m at 1.24 g/t Au

Vancouver, British Columbia–(Newsfile Corp. – December 1, 2025) – Zodiac Gold Inc. (TSXV: ZAU) (“Zodiac Gold” or the “Company”), a West African gold exploration company, is pleased to announce the results of its initial trenching program at the highly prospective Ben Ben target, part of the Company’s flagship Todi Gold Project in Liberia. Ben Ben is one

Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025

NobleCon is the preeminent showcase of small and microcap companies Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focusedbiopharmaceutical company,today announced that Robb Knie, Chief Executive Officer, is scheduled to present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference in Boca Raton, FL. https://mma.prnewswire.com/media/644804/Hoth_Therapeutics_Logo.jpg To learn more about NobleCon and registration to attend

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference

(NasdaqGM:NRXP), WILMINGTON, Del., Dec. 01, 2025 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, the “Company”, “NRx”), a clinical-stage biopharmaceutical company and HOPE Therapeutics, an interventional psychiatry network owned by NRx, today announced that its Founder, Chairman, and Chief Executive Officer, Jonathan Javitt, M.D., M.P.H will present at NobleCon21 – Noble Capital Markets' Twenty First

Highland Critical Minerals Corp. Obtains Final Order for Plan of Arrangement

Toronto, Ontario–(Newsfile Corp. – December 1, 2025) – Highland Critical Minerals Corp. (CSE: HLND) (FSE: U8X) (“Highland” or the “Company“), is pleased to announce that it obtained a final order on November 28, 2025 from the Supreme Court of British Columbia (the “Final Order“) approving the previously-announced statutory plan of arrangement under section 288 of

Homerun Resources Inc. Executes NREL Enduring Thermal Energy Storage Global Intellectual Property Agreement Including New Patent Application and EMS Integration

KEY POINTS Homerun Energy USA, Inc. has executed a global Intellectual Property Agreement, or option agreement, with Alliance for Sustainable Energy LLC., the manager and operator of the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL) covering the intellectual property related to NREL’s particle-based thermal energy storage systems. Homerun also announces that a new

Burcon Insiders Increase Commitment to Participate in Non-Brokered Private Placement of Convertible Debentures

Vancouver, British Columbia–(Newsfile Corp. – December 1, 2025) – Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (“Burcon” or the “Company“), a global technology leader in plant-based protein innovation, is pleased to announce that the Company insiders (“Insiders”) have increased their commitment to participating in the previously announced non-brokered private placement (the “Offering”) (see news release of the

Lotus Creek Exploration Inc. Announces Inaugural Monthly Report to Shareholders and a New Corporate Presentation

Calgary, Alberta–(Newsfile Corp. – December 1, 2025) – Lotus Creek Exploration Inc. (TSXV: LTC) (“Lotus Creek” or the “Company”) is pleased to announce that the inaugural Monthly Report to Shareholders and a new Corporate Presentation have been posted to the Company’s website. MONTHLY REPORT Lotus Creek is excited to announce the new Monthly Report to Shareholders,

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 – Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference GlobeNewswire December 01, 2025 WILMINGTON, Del., Dec. 01, 2025 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, the “Company”, “NRx”), a clinical-stage biopharmaceutical company and HOPE Therapeutics, an interventional psychiatry network owned by NRx,

SoftExpert celebrates 30 years and transforms the American market with the launch of SoftExpert Suite 3.0

The launch of version 3.0 consolidates 30 years of leadership in corporate management and drives SoftExpert's expansion beyond the USA With a strong presence in over 50 countries, SoftExpert, a multinational headquartered in Orlando specializing in software solutions for compliance, governance, and business management, announces a new wave of growth with the release of SoftExpert

Scroll to Top